The impact of tumor growth on plasma homocysteine levels and tissue-specific DNA methylation in Walker-256 tumor-bearing rats

Experimental Oncology

Volumn 29, Issue 4, 2007, Pages 262-266

  Pryzimirska, T V ^a   Pogribny, I P ^b   Chekhun, V F ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

DNA methylation; Homocysteine; Hyperhomocysteinemia; Walker 256 mammary carcinoma

Indexed keywords

HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HYPERHOMOCYSTEINEMIA; NONHUMAN; RAT; TUMOR GROWTH; WALKER CARCINOMA;

ANIMALS; DNA METHYLATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOCYSTEINE; MAMMARY NEOPLASMS, ANIMAL; RATS; RATS, WISTAR; TUMOR MARKERS, BIOLOGICAL;

EID: 39049117848     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
2. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Ann Rev Pharmacol Toxicol 2005; 45: 629-56.
3. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-92.
4. Feinberg AP, Tycko B. The history of cancer epigenetics. Nature Rev Cancer 2004; 4: 143-5.
5. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007; 1775: 138-62.
6. Calvisi DF, Ladu S, Gorden A, et al. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellar carcinoma. J Clin Invest 2007; 117: 2713-22.
7. Chiang PK, Gordon RK, Tal J, et al. S-Adenosylmethionine and methylation. FASEB J 1996; 10: 471-80.
8. Ulrey CL, Liu L, Andrews LG, et al. The impact of metabolism on DNA methylation. Hum Mol Genetics 2005; 14: R139-47.
9. Yi P, Melnyk S, Pogribna M, et al. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosyl- homocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275: 29318-23.
10. Castro R, Rivera I, Blom HJ, et al. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J inherit Metab Dis 2006; 29: 3-20.
11. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diabetes Vasc Dis Res 2007; 4: 143-9.
12. van der Put NM, Blom HJ. Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur J Obstet Gynecol Reprod Biol 2000; 92: 57-61.
13. Morris MS. Homocysteine and Alzheimer's disease. Lancet Neurol 2003; 2: 425-8.
14. Lucock MD. Synergy of genes and nutrients: the case of homocysteine. Curr Opin Clin Nutr Matab Care 2006; 9: 748-56.
15. Wu LL, Wu JT. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 2002; 322: 21-8.
16. Eleftheriadou A, Chalastras T, Ferekidou E, et al. Association between squamous cell carcinoma of the head and neck and serum folate and homocysteine. Anticancer Res 2006; 26: 2345-8.
17. Battistelli S, Vittoria A, Stefanoni M, et al. Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma. World J Gastroenterol 2006; 12: 6128-32.
18. Chou YC, Lee MS, Wu MH, et al. Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case-control study in Taiwan. Breast Cancer Res Treat 2007; 101: 199-205.
19. Ozkan Y, Yardim-Akaydin S, Firat H, et al. Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients. Anticancer Res 2007; 27: 1185-9.
20. Falvo N, Ghiringhelli F, Berthier S, et al. Case-control study of hyperhocysteinemia in cancer-bearing patients in a internal medicine department. Rev Med Int 2007; 28: 520-5.
21. Shukeir N, Pakneshan P, Chen G, et al. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res 2006; 66: 9202-10.
22. Pogribny IP, Yi P, James SJ. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem Biophys Res Commun 1999; 262: 624-8.
23. James SJ, Melnyk S, Pogribna M, et al. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002; 132: 2361S-6S.
24. Brosnan JT, Jacobs RL, Stead LM, et al. Methylation demand: a key determinant of homocysteine metabolism. Acta Biochim Pol 2004; 51: 405-13.
25. Noga AA, Stead LM, Zhao Y, et al. Plasma homocysteine is regulated by phospholipid methylation. J Biol Chem 2003; 278: 5952-5.
26. Hartz CS, Schalinske KL. Phosphatidylethanolamine N-methyltransferase and regulation of homocysteine. Nutr Rev 2006; 64: 465-7.